Cataract Surgery in Patients With Corneal Disease - Scorecard - MDSpire

Cataract Surgery in Patients With Corneal Disease

  • By

  • Julie Greenbaum, editor

  • April 1, 2025

  • 4 min

Share

Clinical Scorecard: Cataract Surgery in Patients With Corneal Disease

At a Glance

CategoryDetail
ConditionCataracts in patients with various corneal diseases
Key MechanismsCorneal diseases affect IOL selection accuracy, may progress post-surgery, and limit visual outcomes
Target PopulationPatients with cataracts and concurrent corneal diseases such as dry eye, ABMD, HSV keratitis, keratoconus, and Fuchs endothelial corneal dystrophy
Care SettingOphthalmology surgical and preoperative assessment settings

Key Highlights

  • Significant dry eye impairs keratometry readings and must be treated before biometry for accurate IOL calculations.
  • Anterior basement membrane dystrophy requires treatment if symptomatic or if premium IOL is planned; topography should be obtained and stabilized before surgery.
  • Herpes simplex keratitis should be inactive for at least 3 months before surgery with antiviral prophylaxis to reduce recurrence risk.

Guideline-Based Recommendations

Diagnosis

  • Obtain corneal topography in all cataract patients, especially those with ABMD or irregular astigmatism.
  • Document keratoconus stability before cataract surgery; consider corneal cross-linking if progression is present.
  • Assess Fuchs endothelial corneal dystrophy severity to guide surgical planning.

Management

  • Treat ocular surface disease, particularly dry eye, prior to biometry and surgery.
  • Treat ABMD with epithelial debridement (± diamond burr) or phototherapeutic keratectomy and wait at least 3 months for topography stabilization before biometry.
  • Ensure HSV keratitis is inactive for ≥3 months and provide antiviral prophylaxis perioperatively.
  • Use limbal or scleral incisions in keratoconus to minimize induced astigmatism.
  • Avoid toric IOLs in irregular corneas; consider toric IOL only in stable keratoconus patients with good refraction response and no contact lens plans.
  • In mild Fuchs dystrophy, perform cataract surgery alone with extra viscoelastic and techniques minimizing phaco energy.

Monitoring & Follow-up

  • Monitor ocular surface status pre- and postoperatively to manage dry eye exacerbation.
  • Follow corneal topography post-ABMD treatment to confirm stability before proceeding with IOL calculations.
  • Observe for HSV keratitis recurrence after surgery.
  • Monitor endothelial cell health and graft status when combined procedures are performed.

Risks

  • Cataract surgery and postoperative NSAIDs may exacerbate dry eye.
  • Surgery may trigger HSV keratitis recurrence if disease is active.
  • Toric IOLs in irregular corneas may complicate future contact lens fitting and manifest astigmatism if keratoplasty is needed.
  • Combined triple procedures risk graft adherence issues, endothelial cell loss, and increased graft rejection.

Patient & Prescribing Data

Patients with cataracts and coexisting corneal diseases including dry eye, ABMD, HSV keratitis, keratoconus, and Fuchs dystrophy

Preoperative ocular surface optimization, disease-specific corneal treatments, and careful IOL selection improve surgical outcomes and reduce complications.

Clinical Best Practices

  • Treat dry eye thoroughly before biometry to ensure accurate keratometry and IOL power calculation.
  • Delay cataract surgery until corneal topography stabilizes after ABMD treatment (minimum 3 months).
  • Ensure HSV keratitis is quiescent for at least 3 months and use antiviral prophylaxis perioperatively.
  • Select incision sites to minimize astigmatism in keratoconus and avoid toric IOLs in irregular corneas.
  • In mild Fuchs dystrophy, use extra viscoelastic and low phaco energy techniques during cataract surgery to protect endothelium.

References

Original Source(s)

Related Content